cnbc
Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
CNBC • 1 YEAR AGO
JPMorgan says U.S. investors may be wrong to shrug off Trump's tariff push, high stock valuations
CNBC • 1 YEAR AGO
Wall Street firms say this obesity beneficiary is a buy, with one calling for more than 85% upside
CNBC • 1 YEAR AGO
Home Depot earnings beat Wall Street estimates, as retailer breaks comparable sales losing streak
CNBC • 1 YEAR AGO
Markets relieved by German election result, but key industries remain mired in uncertainty
CNBC • 1 YEAR AGO
Europe stocks rise; BAE Systems up 4% as UK's Starmer announces higher defense spending
CNBC • 1 YEAR AGO